1185 related articles for article (PubMed ID: 32270184)
1. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
[TBL] [Abstract][Full Text] [Related]
2. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
3. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
4. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures.
Chan RW; Chan MC; Agnihothram S; Chan LL; Kuok DI; Fong JH; Guan Y; Poon LL; Baric RS; Nicholls JM; Peiris JS
J Virol; 2013 Jun; 87(12):6604-14. PubMed ID: 23552422
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
[TBL] [Abstract][Full Text] [Related]
6. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R
Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Hou Y; Cai JP; Zhang AJ; Zhou J; Yuan S; To KK; Hung IF; Cheung TT; Ng AT; Hau-Yee Chan I; Wong IY; Law SY; Foo DC; Leung WK; Yuen KY
Cell Mol Gastroenterol Hepatol; 2021; 11(3):771-781. PubMed ID: 33010495
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
Rokni M; Ghasemi V; Tavakoli Z
Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
[TBL] [Abstract][Full Text] [Related]
9. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
[TBL] [Abstract][Full Text] [Related]
10. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
11. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.
Chu H; Chan JF; Yuen TT; Shuai H; Yuan S; Wang Y; Hu B; Yip CC; Tsang JO; Huang X; Chai Y; Yang D; Hou Y; Chik KK; Zhang X; Fung AY; Tsoi HW; Cai JP; Chan WM; Ip JD; Chu AW; Zhou J; Lung DC; Kok KH; To KK; Tsang OT; Chan KH; Yuen KY
Lancet Microbe; 2020 May; 1(1):e14-e23. PubMed ID: 32835326
[TBL] [Abstract][Full Text] [Related]
12. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
[TBL] [Abstract][Full Text] [Related]
13. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.
Song TZ; Zheng HY; Han JB; Jin L; Yang X; Liu FL; Luo RH; Tian RR; Cai HR; Feng XL; Liu C; Li MH; Zheng YT
Zool Res; 2020 Sep; 41(5):503-516. PubMed ID: 32772513
[TBL] [Abstract][Full Text] [Related]
14. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
Astuti I; Ysrafil
Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
[TBL] [Abstract][Full Text] [Related]
16. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
[TBL] [Abstract][Full Text] [Related]
17. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis.
Zhou J; Chu H; Li C; Wong BH; Cheng ZS; Poon VK; Sun T; Lau CC; Wong KK; Chan JY; Chan JF; To KK; Chan KH; Zheng BJ; Yuen KY
J Infect Dis; 2014 May; 209(9):1331-42. PubMed ID: 24065148
[TBL] [Abstract][Full Text] [Related]
18. A contemporary review on pathogenesis and immunity of COVID-19 infection.
Mirzaei R; Karampoor S; Sholeh M; Moradi P; Ranjbar R; Ghasemi F
Mol Biol Rep; 2020 Jul; 47(7):5365-5376. PubMed ID: 32601923
[TBL] [Abstract][Full Text] [Related]
19. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S
Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
